You just read:

BioDelivery Sciences Announces Randomization Target Reached in Clinical Trial of Clonidine Topical Gel for the Treatment of Painful Diabetic Neuropathy

News provided by

BioDelivery Sciences International, Inc.

04 Aug, 2016, 07:00 ET